Cargando…
Understanding the agreements and controversies surrounding childhood psychopharmacology
The number of children in the US taking prescription drugs for emotional and behavioral disturbances is growing dramatically. This growth in the use of psychotropic drugs in pediatric populations has given rise to multiple controversies, ranging from concerns over off-label use and long-term safety...
Autores principales: | Parens, Erik, Johnston, Josephine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275214/ https://www.ncbi.nlm.nih.gov/pubmed/18261228 http://dx.doi.org/10.1186/1753-2000-2-5 |
Ejemplares similares
-
Controversies concerning the diagnosis and treatment of bipolar disorder in children
por: Parens, Erik, et al.
Publicado: (2010) -
Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies
por: Parens, Erik, et al.
Publicado: (2009) -
The controversy surrounding OxyContin abuse: issues and solutions
por: Jayawant, Sujata S, et al.
Publicado: (2005) -
Controversy and Agreement Among Guidelines Defining Ambulatory Hypertension in Children
por: Venettacci, Oliver, et al.
Publicado: (2020) -
The ethics of psychopharmacological research in legal minors
por: Tan, Jacinta OA, et al.
Publicado: (2008)